(Q80008151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

randomized controlled trial

27 December 2019

main subject

1 reference

1 reference

M Praga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

V Barrio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

G Fernández Juárez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

J Luño

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Grupo Español de Estudio de la Nefropatía Membranosa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

21 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

924-930

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17377504%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5002215

27 December 2019

exact match

0 references

cites work

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Idiopathic membranous nephropathy: outline and rationale of a treatment strategy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Idiopathic membranous nephropathy: The natural history of untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Idiopathic membranous nephropathy: definition and relevance of a partial remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Rituximab in idiopathic membranous nephropathy: a one-year prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021

Use of mycophenolate mofetil in resistant membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002215

7 January 2021